Physician profile
Gregory N Woods
NPI 1821044066
$3,616.56
in general payments reported to CMS, 2019-2025
39 companies · $588 in 2025
The $588 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $399 · 2020: $155 · 2021: $408 · 2022: $602 · 2023: $660 · 2024: $805 · 2025: $588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,053.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,052.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,201.88 | 2019-2025 | Qulipta, Vraylar, Teflaro |
| Novo Nordisk INC | $483.06 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $258.87 | 2019-2024 | Otezla, Repatha |
| Astellas Pharma US INC | $234.80 | 2023-2025 | Veozah |
| Allergan, INC. | $123.34 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $107.38 | 2019-2024 | Xarelto |
| Exact Sciences Corporation | $103.71 | 2023-2024 | Cologuard Collection Kit |
| Lilly USA, LLC | $98.23 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $88.55 | 2019-2025 | |
| Philips North America LLC | $85.76 | 2022-2023 | |
| Aimmune Therapeutics, INC. | $83.67 | 2024 | |
| Organon LLC | $58.46 | 2022-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $56.24 | 2021-2025 | |
| Glaxosmithkline, LLC. | $52.48 | 2021-2025 | Bexsero, Shingrix |
| Merck Sharp & Dohme LLC | $44.87 | 2024 | Gardasil, Capvaxive, Gardasil 9 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Woods listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.